(Q52066035)

21 April 2018

title

Standardization, analytical validation, and quality control of intermediate endpoint biomarkers. (English)

1 reference

21 April 2018

0 references

1 reference

Veltri RW

1

1 reference

21 April 2018

Miller MC

series ordinal

2

1 reference

21 April 2018

An G

series ordinal

3

1 reference

21 April 2018

language of work or name

English

0 references

publication date

1 April 2001

1 reference

21 April 2018

published in

Urology

1 reference

21 April 2018

volume

57

1 reference

21 April 2018

issue

4 Suppl 1

1 reference

21 April 2018

page(s)

164-170

1 reference

21 April 2018

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

Prostate cancer incidence and mortality rates among white and black men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

Molecular and cellular biology of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

The multistep nature of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

Isolation and androgen regulation of the human homeobox cDNA, NKX3.1

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900965-1

7 January 2021

10.1016/S0090-4295(00)00965-1

Identifiers

DOI

1 reference

21 April 2018

PubMed ID

11295618

1 reference

21 April 2018